Immunogenicity and Safety of Standard-Titer AIK-C Measles Vaccine in Nine-Month-Old Infants
Authors:
- Li-Min HuangLHLi-Min Huang
- Yung-Tai ShihYSYung-Tai Shih
- Jong-Ming ChenJCJong-Ming Chen
- Tzong-Ming JiangTJTzong-Ming Jiang
- Chang-Hai TsaiCTChang-Hai Tsai
- Chin-Yun LeeCLChin-Yun Lee
- 1 January 1999
- journal article
- research article
- Published by SAGE Publications in Viral Immunology
- Vol. 12 (4) , 343-348
Abstract
Because of the interference by maternal antibody before 1 year of age, the Schwarz strain of measles vaccine, which has been routinely used in Taiwan, must be given at 9 months and 15 months of age to ensure an optimal immune response. The AIK-C strain of measles vaccine has been reported to be highly immunogenic. This study evaluated the immunogenicity and safety of the AIK-C vaccine in 9-month-old Taiwanese infants. A total of 135 infants were recruited and were randomly assigned to receive either Schwarz vaccine (68 cases) or AIK-C vaccine (67 cases). Measles antibodies were assayed before and 1 month after the vaccination. Sixty-five (97%) infants who received the AIK-C vaccine seroconverted after the vaccination, whereas the seroconversion rate in those receiving the Schwarz vaccine was 77% (P = 0.001). The incidences of adverse reactions were comparable between the two groups. We conclude that even in 1990s, the failure rate of Schwarz vaccine in 9-month-old infants is still high. The AIK-C vaccine is more immunogenic in infants and its long-term immunogenicity and safety deserve further evaluation.Keywords
This publication has 23 references indexed in Scilit:
- Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium-or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, ZaireVaccine, 1994
- Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: Increased female mortality rateThe Journal of Pediatrics, 1993
- Mortality and morbidity after high titre measles vaccine in MexicoThe Lancet, 1992
- Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccineThe Pediatric Infectious Disease Journal, 1991
- Immunization of Six-Month-Old Infants with Different Doses of Edmonston–Zagreb and Schwarz Measles VaccinesNew England Journal of Medicine, 1990
- IMMUNIZATION OF YOUNG INFANTS WITH HIGH DOSES OF SCHWARTZ MEASLES VACCINEThe Pediatric Infectious Disease Journal, 1988
- EFFECTS OF DOSE AND STRAIN OF VACCINE ON SUCCESS OF MEASLES VACCINATION OF INFANTS AGED 4-5 MONTHSThe Lancet, 1988
- COMPARISON OF EDMONSTON-ZAGREB AND SCHWARZ STRAINS OF MEASLES VACCINE GIVEN BY AEROSOL OR SUBCUTANEOUS INJECTIONThe Lancet, 1987
- IMMUNISATION OF 4-6 MONTH OLD GAMBIAN INFANTS WITH EDMONSTON-ZAGREB MEASLES VACCINEThe Lancet, 1984
- Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failureThe Journal of Pediatrics, 1977